This is an incredibly useful brief (less than 30 minutes) video by a leader in Alzheimer’s Disease, Dr. Phillip Scheltens. One of the most interesting part of the lecture is Dr. Schelten’s discussion of how to evaluate the complaint of mild cognitive impairment when all of the neuropsychological tests are normal.
Advances in Alzheimer’s Disease: Imaging and Biomarker Research [Alternate Title – Diagnosing Alzheimer’s Disease Before Dementia: The Role of Biomarkers]:
Published on Dec 4, 2013The Dementia Webcast Series assists health care providers who treat patients with dementia to stay abreast of current research on the latest advances in diagnosis and treatment presented at the Dementia 2012 conference. In this webcast, Dr. Philip Scheltens reviews using biomarkers for early diagnosis of Alzheimer’s disease (AD) and the benefits of early diagnosis.
To participate in other online education, visit https://www.clevelandclinicmeded.com/
The video was produced by the Cleveland Clinic Foundation Center for Continuing Education and the Lou Ruvo Center for Brain Health.
